Instillation of Ophthalmic Formulation Containing Nilvadipine Nanocrystals Attenuates Lens Opacification in Shumiya Cataract Rats

We developed ophthalmic formulations based on nilvadipine (NIL) nanocrystals (NIL-NP dispersions; mean particle size: 98 nm) by using bead mill treatment and investigated whether the instillation of NIL-NP dispersions delivers NIL to the lens and prevents lens opacification in hereditary cataractous...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Ryoka, Yamada, Shigehiro, Otake, Hiroko, Nakazawa, Yosuke, Oka, Mikako, Yamamoto, Naoki, Sasaki, Hiroshi, Nagai, Noriaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709220/
https://www.ncbi.nlm.nih.gov/pubmed/34959281
http://dx.doi.org/10.3390/pharmaceutics13121999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709220/
https://www.ncbi.nlm.nih.gov/pubmed/34959281
http://dx.doi.org/10.3390/pharmaceutics13121999

Ejemplares similares